Agallas Equities Launches $400 Million Real Estate Fund Focused on Transformative Development in the Dominican Republic GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Agallas Equities LLC, a New York-based real estate investment and development firm, today announced the launch of its inaugural fund, the Agallas Equities Real Estate Fund I […]

CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors GlobeNewswire October 21, 2025 MELBOURNE, Australia and PALM BEACH, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) — CYIOS Corporation (OTC: CYIO) today announced that David Lewis has stepped down from his roles with CYIOS, and as part of this transition,

Sienna Announces The Opening of Its Long-Term Care Community Redevelopment in Brantford, Ontario GlobeNewswire October 21, 2025 MARKHAM, Ontario, Oct. 21, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company“) (TSX: SIA) announced today that it has officially opened its Oakwood Commons Community in Brantford, Ontario, the Company's second long-term care redevelopment

Amaze Welcomes Global Gaming Influencer Mystic7 with the Launch of His Official Store With Over 3 Million Fans Worldwide, Mystic7 Brings Exclusive Merchandise to Life Through Amaze Storefront GlobeNewswire October 21, 2025 NEWPORT BEACH, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered commerce, today

Artificial Intelligence Opportunities are Sky Rocketing as Global AI In Healthcare Market is Projected to Reach $504 Billion by 2032 GlobeNewswire October 21, 2025 MarketNewsUpdates News Commentary NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — The emergence of Artificial Intelligence (AI) in healthcare is not only growing year to year but it is groundbreaking, and

Vertex Announces CEO Retirement and Succession Plan GlobeNewswire October 21, 2025 Christopher Young to Succeed David DeStefano as Vertex's President and Chief Executive Officer Leadership Transition to Occur on November 10, 2025; David DeStefano to Serve as Non-Executive Chairperson Announces Preliminary Third Quarter Financial Results KING OF PRUSSIA, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) —

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL(R) GlobeNewswire October 21, 2025 BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received

AmpliTech Group Positioned for Strong Growth in ORAN 5G and Quantum Technologies Through 2035 GlobeNewswire October 21, 2025 HAUPPAUGE, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer and manufacturer of advanced signal-processing components for satellite, 5G/6G networks, and quantum systems, today announced its strategic positioning to capitalize

SEALSQ Joins the MIT Media Lab's Global Community of Member Organizations GlobeNewswire October 21, 2025 Geneva, Switzerland, Oct. 21, 2025 (GLOBE NEWSWIRE) — Exploring the intersection of security, sustainability, and human-centered innovation SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome GlobeNewswire October 21, 2025 Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the US Orphan Drug Designation previously granted by the European Medicines Agency in May 2025 ASHBURN, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) —